MichaelScordoMD

PubMed

• 1 citations
  CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.
  Ross S Firestone, Devin McAvoy, Tala Shekarkhand, Edith Serrano, Issam Hamadeh, Alice Wang, Menglei Zhu, Wei Ge Qin, Dhwani Patel, Carlyn R Tan, Malin Hultcrantz, Sham...> ;Blood Advances. 2024 Apr 9
• BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cel...
  Robert Stuver, Agrima Mian, Samantha Brown, Sean Devlin, Paolo F Caimi, Stephanie Chinapen, Parastoo Dahi, Robert Dean, Zachary D Epstein-Peterson, Brian Hill, Steven ...> ;American Journal of Hematology. 2024 Mar 25
• Successful use of narsoplimab to treat allogeneic transplant-associated thrombotic microangiopathy while maintaining sirolimus.
  Mohammad Alhomoud, Michael Scordo, Miguel-Angel Perales> ;Bone Marrow Transplantation. 2024 Mar 11
• Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma.
  Lesokhin, A., Nath, K., Shekarkhand, T., Nemirovsky, D., Derkach, A., Costa, B., Nishimura, N., Farzana, T., Rueda, C., Chung, D., Landau, H., Lahoud, O., Scordo, M., ...> ;Research Square. 2024 Feb 7
• Measurement of ThioTEPA and Its Metabolite TEPA in Plasma and Cerebrospinal Fluid by Turbulent Flow Chromatography-Tandem Mass Spectrometry.
  Ryan C Schofield, Michael Scordo, Gunjan Shah, Dean C Carlow> ;Methods in Molecular Biology. 2024 Jan 1
• Quantification of Clofarabine and Fludarabine in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
  Ryan C Schofield, Michael Scordo, Gunjan Shah, Dean C Carlow> ;Methods in Molecular Biology. 2024 Jan 1
• Simultaneous Determination of Prednisone and Prednisolone in Serum by Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry.
  Ryan C Schofield, Michael Scordo, Gunjan Shah, Dean C Carlow> ;Methods in Molecular Biology. 2024 Jan 1
• Determination of Busulfan and Melphalan in Plasma by Turbulent Flow Chromatography-Tandem Mass Spectrometry.
  Ryan C Schofield, Michael Scordo, Gunjan Shah, Dean C Carlow> ;Methods in Molecular Biology. 2024 Jan 1
• The EAS(E)IX of predicting sepsis after allogeneic hematopoietic cell transplantation.
  Cosmo Fowler, Michael Scordo, Sanjay Chawla> ;Intensive Care Medicine. 2023 Nov 1
• 1 citations
  Reduced-Intensity Compared to Nonmyeloablative Conditioning in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
  Karthik Nath, Kristen Peterson, Samantha Brown, Sean Devlin, Natasia Rodriguez, Juliet Barker, Sergio Giralt, Boglarka Gyurkocza, Ann Jakubowski, Esperanza Papadopoulo...> ;Transplantation and Cellular Therapy. 2024 Jan 1
• Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation.
  Roni Tamari, Michael Scordo, Binni M Kunvarjee, Anthony Proli, Andrew Lin, Jessica Flynn, Christina Cho, Sean Devlin, Elizabeth Klein, Farid Boulad, Maria I Cancio, Ke...> ;Blood Advances. 2023 Sep 26
• 3 citations
  Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma.
  Michael Scordo, Jessica R Flynn, Mithat Gonen, Sean M Devlin, Allison Parascondola, Ana Alarcon Tomas, Roni Shouval, Jamie Brower, David L Porter, Stephen J Schuster, ...> ;Blood Advances. 2023 Sep 26
• 2 citations
  The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation.
  Shlomo Elias, Samantha Brown, Sean M Devlin, Juliet N Barker, Christina Cho, David J Chung, Parastoo B Dahi, Sergio Giralt, Boglarka Gyurkocza, Ann A Jakubowski, Oscar...> ;British Journal of Haematology. 2023 Dec 1
• 1 citations
  Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiot...
  Shanze Arshad, Xi Fang, Kwang W Ahn, Manmeet Kaur, Michael Scordo, Craig S Sauter, Fateeha Furqan, Farrukh T Awan, Mehdi Hamadani> ;Bone Marrow Transplantation. 2023 Nov 1
• Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma.
  Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, D...> ;Blood Cancer Journal. 2023 Jul 25
• 4 citations
  Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma.
  Richard J Lin, Soo Jung Kim, Samantha Brown, Theresa A Elko, Josel D Ruiz, Danielle M Hanley, M Lia Palomba, Miguel-Angel Perales, Gunjan L Shah, Parastoo B Dahi, Mich...> ;Blood Advances. 2023 Jul 25
• 12 citations
  CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.
  Jae H Park, Karthik Nath, Sean M Devlin, Craig S Sauter, M Lia Palomba, Gunjan Shah, Parastoo Dahi, Richard J Lin, Michael Scordo, Miguel-Angel Perales, Roni Shouval, ...> ;Nature Medicine. 2023 Jul 1
• 1 citations
  Linking Body Composition and Nutritional Status with CAR T-cell Efficacy.
  Mariam T Nawas, Michael Scordo> ;Cancer Immunology Research. 2023 Jun 2
• Linking Body Composition and Nutritional Status with CAR T-cell Efficacy.
  Mariam T Nawas, Michael Scordo> ;Cancer Immunology Research. 2023 May 5
• 2 citations
  Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation.
  Michael Scordo, Leah J Gilbert, Danielle M Hanley, Jessica R Flynn, Sean M Devlin, Linh K Nguyen, Josel D Ruiz, Gunjan L Shah, Craig S Sauter, David J Chung, Heather J...> ;Blood Advances. 2023 Apr 25
• 1 citations
  Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort ...
  Neha Korde, Elizabet Tavitian, Donna Mastey, Joseph Lengfellner, Gil Hevroni, Andrew Zarski, Meghan Salcedo, Sham Mailankody, Hani Hassoun, Eric L Smith, Malin Hultcra...> ;Eclinicalmedicine. 2023 Mar 1
• 1 citations
  Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma.
  Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, D...> ;Research Square. 2023 Feb 24
• 5 citations
  EASIX score predicts inferior survival after allogeneic hematopoietic cell transplantation.
  Miriam Sanchez-Escamilla, Jessica Flynn, Sean Devlin, Molly Maloy, Samira A Fatmi, Ana Alarcon Tomas, Silvia Escribano-Serrat, Doris Ponce, Craig S Sauter, Sergio A Gi...> ;Bone Marrow Transplantation. 2023 May 1
• Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
  Matthew J Pianko, Timothy Tiutan, Andriy Derkach, Jessica Flynn, Steven P Salvatore, Insara Jaffer-Sathick, Adriana C Rossi, Oscar Lahoud, Malin Hultcrantz, Urvi A Sha...> ;American Journal of Hematology. 2023 Mar 1
• 10 citations
  Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell Therapy.
  Harper Hubbeling, Emily A Silverman, Laure Michaud, Ana Alarcon Tomas, Roni Shouval, Jessica Flynn, Sean Devlin, N Ari Wijetunga, Kathryn R Tringale, Connie Batlevi, P...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• Join now to see all

Abstracts/Posters

• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Highly Favorable Outcomes with Salvage Radiation Therapy Followed By Autologous Transplant in Relapsed and Refractory DLBCL Patients with Minimal or No Response to Sal...
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical Management
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Pre-Transplant Fecal Microbial Diversity Independently Predicts Critical Illness after Hematopoietic Cell Transplantation
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T Cells
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Early Experience Using Radiotherapy As a Salvage Treatment for Relapsed or Refractory Non-Hodgkin Lymphomas Following CD19 Chimeric Antigen Receptor Modified T-Cell Th...
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• MSKCC Early Experience Using Radiotherapy As a Bridging Strategy for Relapsed Diffuse Large B Cell Lymphoma before CD19 CAR T Therapy
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Delayed Neutrophil Engraftment in Patients Receiving Daratumumab As Part of Their First Induction Regimen for Multiple Myeloma
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Weekly Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab (wKRd-D) Combination Therapy Provides Unprecedented MRD Negativity Rates in Newly Diagnosed Multiple My...
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Dynamic Easix Scores Closely Predict Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplantation
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Multiple Myeloma Patients Treated with Lenalidomide Maintenance Therapy: A Clinical and Correlative Ph...
  Michael Scordo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Homebound Autologous Hematopoietic Cell Transplantation for Plasma Cell Disorders in an Urban Setting Is Safe for Patients and Preferred By Patients and Caregivers 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Double-Unit Cord Blood (CB) Transplantation with Haplo-Identical CD34+ Cells (haplo-dCBT) May Speed Neutrophil Recovery Although Successful Bridging Is Contingent on C... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Dysgeusia Is Associated with Higher Melphalan Pharmacokinetic Levels and Results in Poorer Caloric Intake and Worse Symptom Burden after Autologous Stem Cell Transplan... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Career-Development Lunch Sessions: Adult Clinical Malignant Hematology/BMT 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Join now to see all